concept

RA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about RA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

158Connections
30Hypotheses
5Analyses
0Outgoing
50Incoming
15Experiments
6Debates

Summary

RA is a concept in neurodegeneration research. Key relationships include: implicated in, associated with. Connected to 158 entities in the SciDEX knowledge graph.

View on Wiki →

AI portrait of RA

AI-generated illustration · click image to enlarge

Regenerate portrait ↻
💡 Concept Info
NameRA
Key Genes/ProteinsA2M, ABCA1, ABCB1, ABCG1, ACTB, AGER
Linked Hypotheses18 hypotheses

Wiki Pages (20)

Knowledge base pages for this entity

TRA2B Protein - Transformer-2 Beta

protein · 4438 words

RASGRP1 Gene

gene · 3531 words

HRAS (Harvey Rat Sarcoma Viral Oncogene Homolog)

gene · 3426 words

RAB9A

gene · 3229 words

RRAS3 — Related RAS Virus (R-Ras) Family Member 3

gene · 3166 words

Pathway Diagram

graph TD
    RA["RA"]
    MAP1B["MAP1B"] -->|"implicated in"| RA
    MAP2["MAP2"] -->|"implicated in"| RA
    MAP6["MAP6"] -->|"implicated in"| RA
    GLUT4["GLUT4"] -->|"implicated in"| RA
    PPAR["PPAR"] -->|"implicated in"| RA
    RAB7A["RAB7A"] -->|"implicated in"| RA
    LRP2["LRP2"] -->|"implicated in"| RA
    ACTB["ACTB"] -->|"implicated in"| RA
    CTSD["CTSD"] -->|"implicated in"| RA
    ATG["ATG"] -->|"implicated in"| RA

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (158)

SourceRelationTypeStr
RBPassociated_withprotein0.56
IDH2implicated_ingene0.50
IDH1implicated_ingene0.50
SLC16A2implicated_ingene0.50
SLC16A1implicated_ingene0.50

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl 0.964 neuroscience Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.958 Alzheimer's disease Circuit-level neural dynamics in neurode
Plasma NfL Elevation Secondary to BBB-Associated Transport D 0.940 - What blood-brain barrier permeability ch
Closed-loop transcranial focused ultrasound to restore hippo 0.912 Alzheimer's disease Circuit-level neural dynamics in neurode
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming 0.907 neurodegeneration What are the mechanisms by which gut mic
Gamma entrainment therapy to restore hippocampal-cortical sy 0.895 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener 0.892 neurodegeneration Gene expression changes in aging mouse b
Optimized Temporal Window for Metabolic Boosting Therapy Det 0.887 neurodegeneration How do different microglial subtypes (DA
APOE-Dependent Autophagy Restoration 0.877 neurodegeneration Survival Analysis of AD Patient Cohorts:
eIF2α Phosphorylation Imbalance Creates Integrated Stress Re 0.866 ALS -
Optogenetic restoration of hippocampal gamma oscillations vi 0.865 Alzheimer's disease Circuit-level neural dynamics in neurode
Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated 0.865 molecular neurobiology View
Glymphatic-Mediated Tau Clearance Dysfunction 0.865 neuroscience Proteomics Differential Expression in AD
Closed-loop focused ultrasound targeting EC-II PV interneuro 0.863 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima 0.862 neurodegeneration Variant Annotation and Prioritization of
TREM2-Mediated Microglial Dysfunction Disrupts Perivascular 0.861 neuroscience TREM2 in Alzheimer's Disease: Mechanisms
Circadian Glymphatic Entrainment via Targeted Orexin Recepto 0.860 neurodegeneration Perivascular spaces and glymphatic clear
RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA P 0.858 ALS -
H6: Aberrant eIF2α Phosphorylation Creates Stalled Translati 0.856 neurodegeneration How do pathological stress granules tran
SFPQ Paralog Displacement Triggers Cryptic Polyadenylation a 0.850 ALS -
Elevated CSF/Serum Albumin Quotient Predicts Neurodegenerati 0.850 - What blood-brain barrier permeability ch
TBK1 Loss Locks Microglia in an Aged/Senescent Transcription 0.847 ALS What are the mechanisms by which microgl
Beta-frequency entrainment therapy targeting PV interneuron- 0.846 Alzheimer's disease Circuit-level neural dynamics in neurode
Neutral Sphingomyelinase-2 Inhibition for Synaptic Protectio 0.844 neurodegeneration Lipid raft composition changes in synapt
miR-155/Interferon-gamma Feedback Loop as a Reversible Molec 0.843 neurodegeneration How do different microglial subtypes (DA
ATM Kinase Hyperactivation Triggers DNA Damage Response Over 0.842 ALS -
Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte 0.839 neurodegeneration View
Sequential Iron Chelation (Deferoxamine) and GPX4 Restoratio 0.838 neurodegeneration View
TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio 0.000 ALS What are the mechanisms by which microgl
TBK1 Loss Triggers eIF2α-Mediated Translational Repression T 0.000 ALS What are the mechanisms by which microgl

Mentioning Analyses (5)

Scientific analyses that reference this entity

How does parthenolide specifically modulate ADORA2A signaling to produce antidep

neuropharmacology | 2026-04-25 | 4 hypotheses Top: 0.659

Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas

neurodegeneration | 2026-04-24 | 5 hypotheses Top: 0.790

Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas

neurodegeneration | 2026-04-23 | 7 hypotheses Top: 0.780

What amyloid threshold level is required for optimal clinical benefit in early A

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.577

What are the molecular mechanisms by which GLP-1RAs provide neuroprotective effe

neurodegeneration | 2026-04-14 | 0 hypotheses

Experiments (15)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Plant-based dietary patterns and Alzheimer's disease risk in multiethn clinical Alzheimer's disease and relate 0.950 0.00 human patients proposed N/A
Tet2 modulation in Aβ42-injured mouse hippocampal neurons exploratory Alzheimer's disease 0.900 0.00 primary mouse hippocampal neur proposed N/A
iPSC-NPC effects on astrocytes in vitro ICH model exploratory intracerebral hemorrhage 0.900 0.00 in vitro ICH cell culture mode completed N/A
AMPK knockdown validation experiment exploratory intracerebral hemorrhage 0.880 0.00 astrocyte cell culture proposed N/A
P2RY12-MTOR pathway interaction in VSMCs exploratory atherosclerosis 0.850 0.00 cultured VSMCs proposed N/A
iPSC-NPC transplantation in ICH animal model validation intracerebral hemorrhage 0.850 0.00 animal ICH model proposed N/A
Brain Connectivity-Targeted tACS Trial in Early AD clinical Alzheimer's Disease 0.509 0.50 human postmortem brain tissue proposed $520,000
s:** - Test whether HCN1 knockout specifically in EC layer II accelera falsification Alzheimer's Disease 0.400 0.50 cell_line proposed $80,000
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Positive Indiv clinical Alzheimer's Disease 0.400 0.50 human proposed $6,550,000
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau clinical Alzheimer's Disease 0.400 0.50 cell_line proposed $180,000
Biomarker-Guided Sequential Therapy Selection in Alzheimer's Disease clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
tACS Connectivity Trial in Early Alzheimer's clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Brain Connectivity-Targeted tACS Trial in Early AD clinical Alzheimer's Disease 0.400 0.50 mouse proposed $730,000
Cognitive Reserve Mechanisms in Alzheimer's Disease — Molecular Basis clinical Alzheimer's Disease 0.400 0.50 human completed $6,550,000
Cholinergic System Dysfunction in DLB — Mechanisms and Therapeutic Res clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614] Han QQ, Shen SY, Liang LF, Chen XR, Yu J Brain Behav Immun 2024 1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] Zhang T, Xu D, Trefts E, Lv M, Inuzuka H Science 2023 1
Replating Induces mTOR-Dependent Rescue of Protein Synthesis in Charcot-Marie-To [PMID:41876253] Koenig J, McGuire A, Homedan Y, Alberhas eNeuro 2026 0
S-equol promotes ferroptosis in triple negative breast cancer by coordinating NC [PMID:41925800] Ni F, Huang Z, Cui Y, Huang P, Xue Z, Hu Molecular and cellular biochem 2026 0
Anatomical and neurochemical profiles of somatostatin-positive neurons in the mo [PMID:41796787] Tomioka R, Kobayashi K, Song WJ Neuroscience 2026 0
Subtype-Specific Roles of Anterior Cingulate Cortex Neurons in Pain-Induced Soci [PMID:41799202] Wan X, Yan Z, Zhang Z, Liu X, Yang D, Zh Theranostics 2026 0
Metabolic dysregulation reshapes the immune landscape: The gut microbiota-mTOR a [PMID:41445190] Li J, Li J, Chen K Mol Ther 2026 0
Senecavirus a VP2 protein orchestrates PRDX1 degradation through dual autophagy [PMID:41479169] Li Z, Yang X, Mao J, Zeng P, Qi Y et al. Autophagy 2026 0
Inhibition of mTOR Enhances the Efficacy of Proteasome-Dependent Targeted Protei [PMID:41529091] Liu Y, Sun Y, Song TY, Ni SY, Pu YS et a Cancer Res 2026 0
Microglial metabolic reprogramming in Alzheimer's disease: Pathways, mechanisms, [PMID:41651180] Yang FG, Yang H, Han SW, Wang JT, Gao W Ageing Res Rev 2026 0
mTOR signaling pathway in primary Sjögren's syndrome: Pathogenesis and potential [PMID:41789635] Huo R, Yang Y, Wei C, Yang Y, Meng D et Int J Mol Med 2026 0
Microcystin-LR-induced phosphorylation imbalance and organelle stress: An integr [PMID:41846138] Teng Z, Shahzad A, Xu Z, Xia J, Zhang J J Hazard Mater 2026 0
Copper deficiency impairs oligodendrocyte maturation and social behavior via mit [PMID:41920999] Usui N, Doi M, Berto S, Matsuoka K, Ishi Sci Adv 2026 0
A comparative analysis of pig-to-rhesus corneal xenotransplantation with various [PMID:41928466] Lee SH, Yoon CH, Choi HJ, Lee HJ, Kang H Korean J Ophthalmol 2026 0
Crosstalk between inflammation and autophagy in CeD organoids. [PMID:41933042] Bellomo C, Furone F, Auricchio R, D'Anie Sci Rep 2026 0
Epigenetically regulated pancreatic GABA-somatostatin signaling underlies gestat [PMID:41779871] Zhu H, Luo S, Liu C, Cheng Y, Ren Z, Mo Science translational medicine 2026 0
Therapeutic Potential of Somatostatin and Its Analogues in Alzheimer's Disease: [PMID:41854733] Liu K, Zhang XY, Wang YT, Wang R, Jin RH Molecular neurobiology 2026 0
Targeting the AKT/mTOR axis: pectolinarigenin induces autophagy and apoptosis in [PMID:41924135] Fang Y, Bai J, Bo S, Cui X, Song H, Guo Frontiers in pharmacology 2026 0
Targeting the GSK-3β/mTOR axis: a novel pharmacological strategy for preeclampsi [PMID:41922823] Alshaikh ABA, Al-Kuraishy HM, Abdelaziz Naunyn-Schmiedeberg's archives 2026 0
Platelet proteomic signatures of amyloid β-positive mild cognitive impairment an [PMID:41904574] Cho YE, Kim A, Lee HM, Oh JW, Son SJ, Ro Molecular brain 2026 0

Debates (6)

Multi-agent debates referencing this entity

The debate highlighted that G2019S shows elevated baseline RAB10 phosphorylation

closed · Rounds: 4 · Score: 0.80 · 2026-04-26

Hypothesis debate: Multi-Biomarker Composite Index Surpassing Amyloid PET for Tr

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

How does parthenolide specifically modulate ADORA2A signaling to produce antidep

closed · Rounds: 4 · Score: 0.66 · 2026-04-25

Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas

closed · Rounds: 4 · Score: 0.74 · 2026-04-24

While the study demonstrates dose-response relationships between amyloid levels

closed · Rounds: 4 · Score: 0.76 · 2026-04-16

The study demonstrates significant reduction in dementia risk (HR 0.63) with GLP

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

Related Research

Hypotheses and analyses mentioning RA in their description or question text

Gamma entrainment therapy to restore hippocampal-cortical synchrony

Score: 0.895 · Alzheimer's disease · 2026-04-02

## Mechanistic Overview Gamma entrainment therapy to restore hippocampal-cortical synchrony starts from the claim that m

TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration

Score: 0.892 · neurodegeneration · 2026-04-07

## Mechanistic Overview TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration starts from the claim that mod

Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of M

Score: 0.887 · neurodegeneration · 2026-04-16

## Mechanistic Overview Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of Microglial State

APOE-Dependent Autophagy Restoration

Score: 0.877 · neurodegeneration · 2026-04-02

## Mechanistic Overview APOE-Dependent Autophagy Restoration starts from the claim that modulating MTOR within the disea

Optogenetic restoration of hippocampal gamma oscillations via selective PV inter

Score: 0.865 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activatio

Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated Autophagy Through PV

Score: 0.865 · molecular neurobiology · 2026-04-17

## Mechanistic Overview Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated Autophagy Through PV Interneuron-Spe

Glymphatic-Mediated Tau Clearance Dysfunction

Score: 0.865 · neuroscience · 2026-04-07

## Mechanistic Overview Glymphatic-Mediated Tau Clearance Dysfunction starts from the claim that modulating MAPT within

Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-

Score: 0.863 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-gamma coupling a

TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Faile

Score: 0.862 · neurodegeneration · 2026-04-16

## Mechanistic Overview TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Failed DAM Transition

TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance

Score: 0.861 · neuroscience · 2026-04-12

## Mechanistic Overview TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance starts from the claim

Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation

Score: 0.860 · neurodegeneration · 2026-04-02

## Mechanistic Overview Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation starts from the claim t

H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State

Score: 0.856 · neurodegeneration · 2026-04-22

## Mechanistic Overview H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State starts from the claim that